Ontology highlight
ABSTRACT: Background
Primary prophylactic implantable cardioverter-defibrillators (ICDs) in patients with non-ischaemic cardiomyopathy (NICMP) remains controversial. This study sought to assess the benefit of ICD therapy with or without cardiac resynchronisation therapy (CRT) in patients with NICMP. In addition, data were compared with real-world clinical data to perform a risk/benefit analysis.Methods
Relevant randomised clinical trials (RCTs) published in meta-analyses since DANISH, and in PubMed, EMBASE and Cochrane databases from 2016 to 2020 were identified. The benefit of ICD therapy stratified by CRT use was assessed using random effects meta-analysis techniques.Results
Six RCTs were included in the meta-analysis. Among patients without CRT, ICD use was associated with
SUBMITTER: Theuns DA
PROVIDER: S-EPMC9950314 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature